Neumentum Overview
- Year Founded
-
2017

- Status
-
Private
- Employees
-
6

- Latest Deal Type
-
Series A2
- Latest Deal Amount
-
$10M
- Investors
-
9
Neumentum General Information
Description
Developer of a pharmaceutical platform intended to offer non-opioid pain therapeutics to patients. The company's platform offers four non-opioid drug candidates in development, from different assets to novel chemical entities, in both hospital and retail markets for acute and chronic pain indications, enabling patients to have options for viable non-opioid analgesics that can effectively treat their moderately severe pain.
Contact Information
Website
www.neumentum.comCorporate Office
- 350 Springfield Avenue
- Suite 200
- Summit, NJ 07901
- United States
Corporate Office
- 350 Springfield Avenue
- Suite 200
- Summit, NJ 07901
- United States
Neumentum Timeline
Neumentum Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. Later Stage VC (Series A2) | 08-Nov-2023 | $10M | Completed | Clinical Trials - Phase 3 | ||
4. Later Stage VC (Series A2) | 27-Apr-2023 | Completed | Clinical Trials - Phase 3 | |||
3. Early Stage VC (Series A2) | 31-May-2021 | Completed | Clinical Trials - Phase 3 | |||
2. Early Stage VC (Series A1) | 30-May-2018 | $7.31M | $13.3M | Completed | Clinical Trials - Phase 3 | |
1. Early Stage VC (Series A) | 01-Nov-2017 | $6M | $6M | Completed | Startup |
Neumentum Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series A-2/A | ||||||||
Series A-2/B | ||||||||
Series A1 | 6,210,333 | $0.001000 | $1.18 | $1.18 | 1x | $1.18 | 8.33% | |
Series A | 6,000,000 | $0.001000 | $1 | $1 | 1x | $1 | 8.05% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Neumentum Comparisons
Industry
Financing
Details
Neumentum Competitors (4)
One of Neumentum’s 4 competitors is Avenue Therapeutics, a Corporation company based in Bay Harbor Islands, FL.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Avenue Therapeutics | Corporation | Bay Harbor Islands, FL | ||||
Pacira BioSciences | Formerly VC-backed | Tampa, FL | ||||
Mallinckrodt Pharmaceuticals | Formerly PE-Backed | Dublin, Ireland | ||||
Heron Therapeutics | Formerly VC-backed | San Diego, CA |
Neumentum Patents
Neumentum Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-4136072-A1 | Compositions and methods for treating pain and/or inflammation | Pending | 15-Apr-2020 | ||
EP-4136072-A4 | Compositions and methods for treating pain and/or inflammation | Pending | 15-Apr-2020 | ||
US-20220008390-A1 | Compositions and methods for treating pain and/or inflammation | Inactive | 15-Apr-2020 | A61K31/415 |
Neumentum Signals
Neumentum Investors (9)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Thornapple River Capital | Venture Capital | Minority | ||
Global Equity Ventures | Venture Capital | Minority | ||
AngelMD | Angel Group | Minority | ||
Green Park & Golf Ventures | Venture Capital | Minority | ||
Angel (individual) | Minority |
Neumentum FAQs
-
When was Neumentum founded?
Neumentum was founded in 2017.
-
Where is Neumentum headquartered?
Neumentum is headquartered in Summit, NJ.
-
What is the size of Neumentum?
Neumentum has 6 total employees.
-
What industry is Neumentum in?
Neumentum’s primary industry is Drug Discovery.
-
Is Neumentum a private or public company?
Neumentum is a Private company.
-
What is the current valuation of Neumentum?
The current valuation of Neumentum is
. -
What is Neumentum’s current revenue?
The current revenue for Neumentum is
. -
How much funding has Neumentum raised over time?
Neumentum has raised $55.6M.
-
Who are Neumentum’s investors?
Thornapple River Capital, Global Equity Ventures, AngelMD, Green Park & Golf Ventures, and are 5 of 9 investors who have invested in Neumentum.
-
Who are Neumentum’s competitors?
Avenue Therapeutics, Pacira BioSciences, Mallinckrodt Pharmaceuticals, and Heron Therapeutics are competitors of Neumentum.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »